Stay updated with breaking news from Early Access Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
UTRECHT, The Netherlands and CAMBRIDGE, Mass., June 29, 2023 (GLOBE NEWSWIRE) -- Merus N.V. (NASDAQ:MRUS), a clinical-stage oncology company developing innovative, full-length multispecific antibodies (Biclonics®
/PRNewswire/ -- Mecademic is pleased to announce and showcase its latest robotic innovation at Automatica in Munich. Early Access Program participants are...
New application seamlessly and securely integrates self-serve customer insights from Amplitude with Snowflake data all within the joint customer's Snowflake account
Company’s priority oncology clinical programs continue to advance toward key milestones Additional clinical trial site now open at University of Nebraska for Phase 2 study of Ampligen® for... | June 12, 2023
Imported GMP API across Canadian-US BorderEstablishes supply chain stability in Canada and large US pharmaceutical market